Systems and methods for particle focusing in microchannels

Information

  • Patent Grant
  • 11331670
  • Patent Number
    11,331,670
  • Date Filed
    Wednesday, May 22, 2019
    5 years ago
  • Date Issued
    Tuesday, May 17, 2022
    2 years ago
  • Inventors
  • Original Assignees
  • Examiners
    • Siefke; Samuel P
    • Vo; Quocan B
    Agents
    • Nguyen Tarbet LLC
Abstract
A microfluidic system configured to focus particles suspended in a fluid. One general aspect includes a microfluidic system comprising one or more substrates and a focusing channel formed in the one or more substrates and spanning a length from an inlet to an outlet for receiving a flow of particles suspended in fluid, wherein the particles have a diameter (a) and the focusing channel has a hydraulic diameter (dh).
Description
BACKGROUND OF THE INVENTION

Flow cytometers function by passing individual particles, such as cells, within a stream of fluid past a detector, which measures certain characteristics of each particle and takes actions based on that evaluation. To do that, the flow cytometer must regulate the flow of the sample so that the particles in the sample move into a substantially single-file particle stream, which enables each particle to be measured individually by the detector.


One area where flow cytometers have found practical use is in connection with sexing sperm cells, such as bovine sperm, according to sperm cell characteristics for use by the animal reproduction industry to preselect the sex of animal offspring. The most common method for sexing sperm cells is to discriminate based on DNA content. In this context, sperm is combined with an extender and a luminescent dye to stain the DNA inside the sperm cell. The stained sperm cells are then placed in a sample fluid which is introduced into a channel of a microfluidic chip that uses focusing techniques to orient the sperm cell into a substantially single-file stream. After being properly oriented, the sperm cells are illuminated with a light source (e.g., a laser), which excites the luminescent dye in the DNA, giving off a fluorescent luminescence which is detected by a detector (e.g., a photomultiplier tube (“PMT”) or an avalanche photodiode (APD)). A sperm containing the X chromosome has more DNA than a Y chromosome-bearing sperm, resulting in the X chromosome-bearing sperm producing more luminescence in response to the detection light source. The detected luminescence is monitored and the system takes selective action, e.g., sorting or killing non-selected sexed sperm with a kill laser, on the individual sperm cells to achieve an end product with the desired characteristics, e.g., a sample with a high concentration of either X or Y chromosome-bearing sperm. For example, if female calves are desired (e.g., for dairy production), then the system is calibrated to collect cells having detected luminescence parameters that are what would be expected of an X chromosome-bearing sperm cell. Alternatively, if male calves are desired (e.g., for beef production), then the system is calibrated to collect cells having detected luminescence parameters that are what would be expected of a Y chromosome-bearing sperm cell.


Sperm cells may also be distinguished based on DNA content by other methods that do not utilize a DNA dye. For example, U.S. Pat. No. 8,941,062 describes systems and methods of cytometry involving presenting a single sperm cell to at least one laser source configured to deliver light to the sperm cell in order to induce bond vibrations in the sperm cell DNA and detecting the signature of the bond vibrations. Sperm cells may also be analyzed and distinguished based on the presence or absence of cell surface markers or protein, through binding of a fluorescently labeled ligand, such as an antibody. Other methods for discriminating sperm cells may utilize other features of sperm cells, such as mass or volume, to differentiate between those that contain X-chromosomes and those that contain Y-chromosomes. These discrimination and detection methods similarly permit the cells to be selectively differentiated and for the sample to be sexed.


Sexing techniques include a variety of methods to sort, separate, eliminate, or inactivate unwanted cells. For example, so-called laser kill methods involve exposure of particular cells to a laser with sufficient energy to inactivate the cells. Cells may also be separated into populations through sorting, for example, through droplet formation and deflection as described in U.S. Pat. No. 5,700,692.


In cell discrimination techniques, including sperm cell sexing applications, proper orientation, ordering, and location of the cells within the microfluidic system is essential to effective operation. For example, positioning and orientation are both essential for being able to effectively detect the difference in fluorescence of X- and Y-chromosome bearing sperm cells stained with a DNA-intercalating dye, as both the positioning of cells within the beam of the detection laser and the orientation of the cells with respect to the detector significantly impact the amount of fluorescence detected. Alterations in the fluorescence, in turn, directly affect the ability to distinguish differences in the fluorescence signal between X-chromosome and Y-chromosome bearing cells. Further, during the sexing process, the various techniques used depend on the ability to accurately locate the cells within the fluid stream. For example, in laser kill sexing, the kill laser is narrowly focused in a particular spot and requires that the cells be positioned properly for the exposure to be effective to be inactivating the cell. Positioning of cells within the flow stream (i.e., up, down, left, and right, with respect to the axis of travel) and ordering (i.e., the distance between cells along the axis of travel) are also important for sorting techniques (i.e., droplet formation and deflection, thermal bubble sorting, etc.). Ordering of cells in a sample flow may be non-deterministic (i.e., follows a Poisson distribution) or deterministic (i.e., spacing). Ordering, therefore, refers to control of cell incidence in the sample flow.


Hydrodynamic focusing has been utilized to align cells, including sperm cells, in flow cytometry applications for many years, but it may have drawbacks. First, hydrodynamic focusing may involve multiple fluid streams, including one or more sheath fluid streams. Sheath fluid is consumable in the flow cytometric process and can be a significant cost. In addition, hydrodynamic focusing may involve microfluidic chips being designed and produced with complex sample and sheath flow channels, leading to relatively high costs for the microfluidic chips. The number of flow controllers required for each number of fluid inlets may also impact the cost. Further, hydrodynamic focusing relies on a consistent flow rate of the sheath flow, and fluctuations in flow rate, for example, due to a loss of pressure or occlusion of a sheath channel, can have adverse effects on cytometer performance.


Inertial flow focusing has been utilized for cell types, such as white blood cells and cancer cells. Those cells are significantly larger than sperm cells and are uniformly shaped (i.e., substantially spherical). In contrast, sperm cells are significantly smaller, non-uniform, and have a tail. As a result, the balance of forces acts differently on sperm cells than on other cell types.


SUMMARY OF THE INVENTION

Certain embodiments of the claimed invention are summarized below. These embodiments are not intended to limit the scope of the claimed invention, but rather serve as brief descriptions of possible forms of the invention. The invention may encompass a variety of forms which differ from these summaries.


According to an embodiment, particle focusing is achieved using a microchannel, wherein the ratio of the particle diameter (a) to the hydraulic diameter of the channel (Dh), defined by the formula a/Dh, is between about 0.03 and about 0.06, and/or wherein the ratio of curvature (radius “r” or “critical parameter”) to the hydraulic diameter of the channel, defined by the formula 2ra2/Dh3, is less than about 0.03.


As used herein, “focusing” refers to the spatial organization of cells into a desired formation, in particular, into a defined spatial width with reference to an axis along which the cells are moving in a microfluidic channel, and/or relative to a defined point of reference, such as the detection or kill laser focus point or both). In an embodiment, a focused flow of cells will all be within 3-5 times a given cell dimension (i.e., width, height, or length) of the center line of the axis of travel. In other embodiments, a focused flow of cells will all be within 2-3 times the cell dimension and in other embodiments within 1-2 times the cell dimensions.


Upon entering the microfluidic system, cells are initially unfocused (i.e., not within the desired spatial parameters); various forces can act on the cells within the flow stream to bring them within the desired spatial parameters (i.e., the cells are focused).


Other aspects will be apparent to one of ordinary skill in the art upon review of the description and exemplary aspects and embodiments that follow.





BRIEF DESCRIPTION OF THE DRAWINGS

For the purpose of illustrating the disclosure, there are depicted in the drawings certain features of the aspects and embodiments of the disclosure. However, the disclosure is not limited to the precise arrangements and instrumentalities of the aspects depicted in the drawings.



FIG. 1A shows a repetitively curved portion of a microchannel according to certain aspects of an embodiment of the present disclosure. FIG. 1B shows a modified inertial focusing design according to certain aspects of an embodiment of the present disclosure. FIG. 1C shows a different modified inertial focusing design according to certain aspects of an embodiment of the present disclosure. FIG. 1D shows an inertial focusing design according to certain aspects of an embodiment of the present disclosure.



FIGS. 2A and 2B show enlarged views of a curved segment of an embodiment of the microchannel of FIG. 1.



FIGS. 3A and 3B show enlarged views of a curved segment of another embodiment of the microchannel of FIG. 1.



FIGS. 4A and 4B show the critical parameter or curvature radius “r”.





DETAILED DESCRIPTION

Before continuing to describe various aspects and embodiments in further detail, it is to be understood that this disclosure is not limited to specific compositions or process steps and may vary. As used in this specification and the appended claims, the singular form “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Ranges expressed herein are inclusive.


An embodiment of the microfluidic chip may be used in connection with sexing sperm cells such as bovine sperm, for example. In particular, the chip may be used in an apparatus that uses flow cytometry for sexing sperm cells according to DNA characteristics for use by the animal reproduction industry to preselect the sex of animal offspring. Briefly, sperm is combined with an extender and a luminescent dye to stain the DNA inside the sperm cell. The dye-stained sperm cells are then placed in a sample fluid which is introduced into a channel of the microfluidic chip. As the sperm cells are not spherical, the microfluidic chip substantially orients the sperm cells to reduce differences in detecting luminescence that may otherwise be caused by differences in the cell's orientation with respect to the detector.


The oriented sperm cells are then illuminated with a light source (e.g., detection laser), which excites the luminescent dye in the DNA, giving off a fluorescent luminescence which is detected by a detector (e.g., a photomultiplier tube (PMT) or an avalanche photodiode (APD)). The sperm containing the X chromosome has more DNA than the Y chromosome-bearing sperm, resulting in the X chromosome-bearing sperm producing more luminescence in response to the original illumination. The difference in total DNA content varies by species; for example in Bos taurus, the X chromosome has approximately 3.8% more DNA than the Y chromosome, which results in approximately a 3.8% difference in fluorescence.


In order to determine which cells to kill, an output signal of the detector representing the amplitude of detected luminescence is monitored. When the detected luminescence value exceeds a set threshold value, an event is considered to have begun. The luminescence value is monitored, and when an inflection point or “peak” is detected, the peak is considered to be the center of the cell, and the peak luminescence value is considered the luminescence value for that cell. If more than one peak is detected in a single event, the peak with the greatest amplitude is considered to be the center of the cell and the peak luminescence value is considered to be the luminescence value for that cell and the other peaks are disregarded.


The luminescence value for each sperm cell is compared to a gate, which has been previously defined, to determine whether the cell displays the desired luminescence. For example, if female calves are desired (e.g., for dairy production), then the gate is selected to include cells having detected luminescence parameters that are what would be expected of an X chromosome-bearing sperm cell. Alternatively, if male calves are desired (e.g., for beef production), then the gate is selected to include cells having detected luminescence parameters that are what would be expected of a Y chromosome-bearing sperm cell.


After passing through the detection laser and having their luminescence detected, the stained sperm cells, still in the stream, then pass into the kill zone. A second light source, e.g., the kill laser, is selectively activated to kill cells that fall outside of the selected gate as they pass through the kill zone.


In other embodiments, particle focusing according to the present invention can be utilized to distinguished sperm cells based on DNA content by methods that do not utilize a DNA dye. For example, U.S. Pat. No. 8,941,062 describes systems and methods of cytometry involving presenting a single sperm cell to at least one laser source configured to deliver light to the sperm cell in order to induce bond vibrations in the sperm cell DNA and detecting the signature of the bond vibrations. In other embodiments, sperm cells may be analyzed and distinguished based on the presence or absence of cell surface markers or protein, through binding of a fluorescently labeled ligand, such as an antibody. Other methods for discriminating sperm cells may utilize other features of sperm cells, such as mass or volume, to differentiate between those that contain X-chromosomes and those that contain Y-chromosomes. These discrimination and detection methods similarly permit the cells to be selectively differentiated and for the sample to be sexed. In further embodiments, sperm cells may be differentiated based on characteristics other than sex. For example, sperm cells may be differentiated on the basis of the presence or absence of a genetic marker or combination of markers, or cell surface protein.


In other embodiments, particle focusing as described herein may be used for semen sexing techniques to sort, separate, eliminate, or inactivate unwanted cells. For example, so-called laser kill methods involve exposure of particular cells to a laser with sufficient energy to inactivate the cells. Cells may also be separated into populations through sorting, for example, through droplet formation and deflection as described in U.S. Pat. No. 5,700,692. Other sorting techniques for use in the present invention include, for example, bubble sort, acoustic, photonic pressure, holographic laser steering, and optical trapping.


The microfluidic chip according to the present design uses a repetitively curved microchannel for ordering and focusing particles in sample fluid mixture. The chip may be composed of one or more substrates in which the channel, or a portion of the channel, is formed. The substrate may be composed of one or more layers. The channel is a three-dimensional structure within the assembled one or more layers of the one or more substrates. In one embodiment, the chip may include two layers, a bottom layer and a top layer, that are stacked together to form the chip. In an embodiment, a repetitively curved portion of the microchannel is formed entirely on the bottom layer, while inlets and outlets to the microchannel may be formed on either or both chip layers. In other embodiments, the microchannel may be formed in two or more layers of a substrate, or multiple substrates. The repetitively curved portion consists of a repeating series of identically-shaped turns as is illustrated in FIG. 1


In use, a sample fluid is introduced into the microchannel through a sample inlet. In the context of bovine semen, the sample includes an ejaculate and a buffer. Upon entering the microchannel, the particles are randomly dispersed within the sample fluid. As the sample flows through, the microchannel of the particles are longitudinally ordered such that, upon exiting the curved portion, the particles are aligned longitudinally in a row. The microchannel may include horizontal/lateral and/or vertical tapering downstream of the curved portion to provide additional focusing of the particles before the fluid moves through a detection region (not shown).



FIGS. 2A and 2B are enlarged views of a curved segment of an embodiment of the microchannel of FIG. 1, FIGS. 3A and 3B are enlarged views of another embodiment of the microchannel of FIG. 1.


The channels depicted above which permit only a single focusing position due to the regulating effect of Dean flows comprise 1.5 turns (FIG. 2A and FIG. 3A) or a single turn (FIG. 2B and FIG. 3B). Referring to FIGS. 2B and 3B, each turn includes a smaller region; the critical parameter is indicated (0.015 mm). In both FIGS. 2 and 3, each turn also includes a larger region (i.e., the lower portion of the turn). The smaller region and larger region are staggered. Together, one smaller region and one larger region constitute a single turn of the microfluidic channel. The turns depicted in FIGS. 2 and 3 are asymmetric, in that, the smaller regions and larger regions are different, and the overall turn is therefore not internally symmetric. In other embodiments, the turn may be symmetric, wherein the left and right sides (i.e., the upper and lower portions of the turn) have the same geometries. In other embodiments, the turns within a focusing channel may include one or more symmetric turns, one or more asymmetric turns, or combinations thereof. In further embodiments, the focusing channels may further include other hydraulic mechanisms to effect the positioning, orientation, and/or ordering of particles within the sample flow.



FIGS. 4A and 4B illustrate how to measure the critical parameter “r”.


As shown in FIG. 4A, the cross-sectional area is determined by the height (H) and width (W) of the microchannel at the smaller region of a turn. FIG. 4B shows the determination of the radius of the smaller region of a turn.


According to an aspect, particle focusing is achieved using a repetitively curved microchannel:


wherein the ratio of the particle diameter (a) to the hydraulic diameter of the channel (Dh), defined by the formula a/Dh is between about 0.03 and about 0.06, and/or


wherein the ratio of curvature (radius “r” or “critical parameter”) to the hydraulic diameter of the channel) defined by the formula 2ra2/Dh3 is less than about 0.03.


In an another aspect, the particle may be bovine sperm cells. Bovine sperm cells are irregularly shaped and sperm cells are smaller, non-uniform (˜3 μm thick×5 μm wide×10 μm long) and have a tail. In this context, the diameter of the cell is considered to be on the order of about 3 μm to about 5 μm. Substantial particle focusing of bovine sperm cells is observed when the microfluidic channel geometries meet one or both of the above conditions. However, if the physical geometries fall outside these ranges, for example, if a/Dh is greater than about 0.06 or less than about 0.03, bovine sperm cells do not focus.


Any number of microfluidic system configurations can be designed to achieve certain specific results and/or properties associated with particle focusing within the various channel geometries. In the examples below, certain properties associated with the systems described herein will now be discussed in more detail. While certain experimental conditions may be discussed in reference to certain properties or parameters, it is to be understood that the properties and parameters are widely applicable to any of the channel geometries.


Example 1

In one aspect, the inertial focusing design (FIG. 1D) was tested in both polydimethylsiloxane (PDMS) and glass at 4 different flow rates. Measurements were taken of core stream width, flat percent, and edge-on percentage, and are shown in Table 1. Figures are shown for PDMS, and where measurements differed when taken in glass chips are shown in parentheses.


Core stream width (e.g., W_68, W_95, W_100) is the measured width of a certain percentage of the core stream, as measured using images taken by a stroboscope of the sample flowing through the microfluidic chip. For instance, W_68 is the measured width of the 68% of the core stream.


Flat percent, which is measured on a stroboscope, is the measurement of cells that are oriented with the broadest cross-section parallel to the top of the channel and therefore also perpendicular to the detector and ablation laser beam paths.


Edge-on percentage, which is measured on a stroboscope, is the measurement of cells with the narrowest cross-section perpendicular to the top of the channel, and therefore parallel to the laser beam paths.














TABLE 1





Flow rate
68% core width
95% core width
100% core width
Flat %
Edge-on %







250 μL/min
6-8 μm
12-16 μm
24-30 μm
37-50% (53-68%)
 23-29% (7-13%)


300 μL/min
4.5-7.5 μm   
 9-14 μm
13-33 μm
42-50% (58-67%)
22-27% (5-7%)


350 μL/min
5-7 μm
10-12.5 μm  
14-28 μm
45-62% (52-68%)
15-21% (6-9%)


400 μL/min
5-10 μm 
12-20 μm
15-31 μm
42-47% (43-68%)
22-24% (7-8%)




(10-12 μm)
(18-21 μm)









Example 2

In another aspect, a modified inertial focusing design (FIG. 1C) was tested. The modified design incorporated an upstream element that includes a curvature in the channel in combination with on-chip dilution to achieve sample focusing in the Z dimension (i.e., top-to-bottom, relative to the direction of travel). The parameters for the curvature of this upstream element were 200 μm radius and 100 μm width (R200W100), 300 μm radius and 100 μm width (R300W75), and 500 μm radius and 100 μm width (R500W100). Dilution was tested a 5%, 10%, 12.5%, and 20% dilution. The inertial focusing portion of the modified design is identical to the inertial focusing design tested in Example 1 and measurements reported in Table 2 include core stream width, flat percent, and edge-on percentage.














TABLE 2






68% core width
95% core width
100% core width
Flat %
Edge-on %


Curvature
5/10/12.5/20%
5/10/12.5/20%
5/10/12.5/20%
5/10/12.5/20%
5/10/12.5/20%


dimensions
dilution (ave.)
dilution
dilution
dilution
dilution







R200W100
3.9/4.3/3.9/4.0 μm
7.7/8.5/7.9/8.1 μm
13.3/14.1/14.0/13.6 μm
53/53/51/47%
11/16/15/19%



(4.0)
(8.0)
(13.8)
(51%)
(15%)


R300W75
—/3.6/3.8/4.0 μm
—/7.1/7.5/8
—/10.1/12.4/14.1 μm
—/58/54/52%
—/10/9/7%



(3.8)
(7.5)
(12.2)
(54%)
(8%)


R500W100
4.2/3.5/6.3/4.8 μm
8.4/7.0/12.5/9.5 μm
18.3/7.8/16.4/12.0
65/57/58/62%
11/8/11/13%



(4.7)
(9.4)
(13.6)
(60%)
(11%)









Example 3

In another aspect, the different modified design was tested, which incorporated a downstream element that includes a curvature in the channel without any on-chip dilution (FIG. 1B). In another aspect, the secondary region downstream of the inertial focusing channel in this design included a secondary input to potentially adjust the entry point of the cells into the curved section of the drifting element, although this element was not utilized during testing. The data in Table 3 provides the same type of results obtained for the modified and unmodified inertial focusing designs discussed in the previous examples. Measurements were taken using a flow rate of 300 μl/min.













TABLE 3





68% core
95% core
100% core




width
width
width
Flat %
Edge-on %







8 μm
16 μm
20 μm
50%
11%









While illustrative embodiments have been illustrated and described, it will be appreciated that various changes can be made therein without departing from the spirit and scope of the invention.

Claims
  • 1. A microfluidic system for focusing sperm cells suspended in a fluid, comprising: a flow of sperm cells suspended in the fluid, the sperm cells having a cell diameter (a);one or more substrates;a focusing channel formed in the one or more substrates and spanning a length from an inlet to an outlet for receiving the flow of sperm cells suspended in the fluid, wherein the focusing channel has a hydraulic diameter (Dh), wherein:a ratio of the cell diameter to the hydraulic diameter of the channel (a/Dh) is between about 0.03 and about 0.06; anda ratio of curvature (critical parameter “r”) to the hydraulic diameter (Dh) defined by the formula 2ra2/Dh3 is less than about 0.03.
  • 2. The microfluidic system of claim 1, wherein the focusing channel comprises a microchannel, the microchannel comprises. comprising a repetitively curved segment.
  • 3. The microfluidic system of claim 2, wherein the repetitively curved segment comprises a repeating series of identically-shaped curved sections.
  • 4. The microfluidic system of claim 3, wherein the identically-shaped curved sections are asymmetrically shaped.
  • 5. The microfluidic system of claim 1, wherein the sperm cells comprise bovine sperm.
  • 6. The microfluidic system of claim 1, wherein an internal geometry of the focusing channel causes the sperm cells to form a focused flow of the sperm cells in the focusing channel.
  • 7. The microfluidic system of claim 6, wherein the sperm cells within the focused flow of the sperm cells are positioned with respect to a center line of an axis of travel within a distance of 3-5 times of a length of any cell dimension.
  • 8. The microfluidic system of claim 1, wherein the sperm cells enter the focusing channel in an unfocused state and exit the focusing channel in a focused state.
  • 9. The microfluidic system of claim 2, wherein the repetitively curved segment comprises one or more symmetrically shaped segments and one or more asymmetrically shaped segments.
  • 10. The microfluidic system of claim 2, wherein the repetitively curved segment comprises a set of turns.
  • 11. The microfluidic system of claim 10, wherein each turn in the set of turns comprises a smaller region and a larger region.
  • 12. A microfluidic system for focusing sperm cells suspended in a fluid, compri sing: a flow of sperm cells suspended in the fluid, the sperm cells having a cell diameter (a);one or more substrates;a focusing channel formed in the one or more substrates and spanning a. length from an inlet to an outlet for receiving the flow of sperm cells suspended in the fluid, wherein the focusing channel has a hydraulic diameter (Di); andwherein a ratio of curvature (critical parameter “r”) to the hydraulic diameter (Dh) defined by the formula 2ra2/Dh3 is less than about 0.03.
  • 13. The microfluidic chip of claim 12, wherein the focusing channel comprises a microchannel comprising a repetitively curved segment.
  • 14. The microfluidic chip of claim 13, wherein the repetitively curved segment comprises a repeating series of identically-shaped curved sections.
  • 15. The microfluidic chip of claim 14, wherein the identically-shaped curved sections are asymmetrically shaped.
  • 16. The microfluidic chip of claim 12, wherein the sperm cells comprise bovine sperm.
  • 17. A method for focusing sperm cells suspended in a fluid, wherein the sperm cells have a cell diameter (a), said method comprising: a. providing a microfluidic chip comprising a focusing channel, wherein the focusing channel has a hydraulic diameter (Dh), wherein a ratio of curvature (critical parameter “r”) to the hydraulic diameter (Dh) defined by the formula 2ra2/Dh3 is less than about 0.03; andb. flowing the sperm cells suspended in the fluid through the focusing channel to form a focused flow of sperm cells.
  • 18. The method of claim 17, wherein the focusing channel comprises a microchannel comprising a repetitively curved segment.
  • 19. The method of claim 18, wherein the repetitively curved segment comprises a repeating series of identically-shaped curved sections.
  • 20. The method of claim 17, wherein the sperm cells comprise bovine sperm.
US Referenced Citations (330)
Number Name Date Kind
3390449 Fox Jul 1968 A
3649829 Randolph Mar 1972 A
3661460 Elking et al. May 1972 A
3710933 Fulwyler et al. Jan 1973 A
3764901 Kachel Oct 1973 A
3791517 Friedman Feb 1974 A
4175662 Zold Nov 1979 A
4325706 Gershman et al. Apr 1982 A
4395397 Shapiro Jul 1983 A
4409106 Furuta et al. Oct 1983 A
4424132 Iriguchi Jan 1984 A
4660971 Sage et al. Apr 1987 A
4667830 Nozaki, Jr. et al. May 1987 A
4765737 Harris et al. Aug 1988 A
4885473 Shofner et al. Dec 1989 A
4919817 Schoendorfer et al. Apr 1990 A
4983038 Ohki et al. Jan 1991 A
5007732 Ohki et al. Apr 1991 A
5030002 North, Jr. Jul 1991 A
5100627 Buican et al. Mar 1992 A
5125749 Leugers et al. Jun 1992 A
5135759 Johnson Aug 1992 A
5180065 Touge et al. Jan 1993 A
5194909 Tycko Mar 1993 A
5229297 Schnipelsky et al. Jul 1993 A
5483469 Van den engh et al. Jan 1996 A
5491550 Dabbs Feb 1996 A
5620857 Weetall et al. Apr 1997 A
5674743 Ulmer Oct 1997 A
5689109 Schultze Nov 1997 A
5752606 Wilson et al. May 1998 A
5800690 Chow et al. Sep 1998 A
5837115 Austin et al. Nov 1998 A
5849178 Holm et al. Dec 1998 A
5858187 Ramsey et al. Jan 1999 A
5879625 Rosianiec et al. Mar 1999 A
5966457 Lemelson Oct 1999 A
5985216 Rens et al. Nov 1999 A
6008010 Greenberger et al. Dec 1999 A
6053856 Hlavinka Apr 2000 A
6071442 Dean et al. Jun 2000 A
6146897 Cohenford et al. Nov 2000 A
6159739 Weigl et al. Dec 2000 A
6159749 Yagang et al. Dec 2000 A
6171865 Weigl et al. Jan 2001 B1
6185664 Jeddeloh Feb 2001 B1
6213151 Jacobson et al. Apr 2001 B1
H1960 Conrad et al. Jun 2001 H
6368871 Christel et al. Apr 2002 B1
6416190 Grier et al. Jul 2002 B1
6416959 Giuliano et al. Jul 2002 B1
6432630 Blankenstein Aug 2002 B1
6451264 Bhullar et al. Sep 2002 B1
6494230 Chow Dec 2002 B2
6506609 Wada Jan 2003 B1
6519032 Kuebler et al. Feb 2003 B1
6519954 Prien et al. Feb 2003 B1
6524860 Seidel et al. Feb 2003 B1
6540895 Spence et al. Apr 2003 B1
6549275 Cabuz et al. Apr 2003 B1
6592821 Wada et al. Jul 2003 B1
6637463 Lei et al. Oct 2003 B1
6727451 Fuhr et al. Apr 2004 B1
6808075 Böhm et al. Oct 2004 B2
6833542 Wang et al. Dec 2004 B2
6838056 Foster Jan 2005 B2
6841388 Dukor et al. Jan 2005 B2
6853654 Mcdonald et al. Feb 2005 B2
6877528 Gilbert et al. Apr 2005 B2
6944324 Tran et al. Sep 2005 B2
6976590 Deshpande et al. Dec 2005 B2
7029430 Hlavinka et al. Apr 2006 B2
7069943 Gilbert et al. Jul 2006 B2
7092154 Yasuda et al. Aug 2006 B2
7104405 Böhm et al. Sep 2006 B2
7208265 Schenk Apr 2007 B1
7195920 Seidel et al. May 2007 B2
7241988 Gruber et al. Jul 2007 B2
7276701 Lendl Oct 2007 B2
7298478 Gilbert et al. Nov 2007 B2
7300803 Lin et al. Nov 2007 B2
7311476 Gilbert et al. Dec 2007 B2
7312085 Chou et al. Dec 2007 B2
7355696 Mueth et al. Apr 2008 B2
7355699 Gilbert et al. Apr 2008 B2
7466734 Day et al. Dec 2008 B1
7472794 Oakey et al. Jan 2009 B2
7482577 Gruber et al. Jan 2009 B2
7492522 Gilbert et al. Feb 2009 B2
7524681 Wolf et al. Apr 2009 B2
7569788 Deshpande et al. Aug 2009 B2
7576861 Gilbert et al. Aug 2009 B2
7584857 Böhm et al. Sep 2009 B2
7611309 Gilbert et al. Nov 2009 B2
7670471 Quake et al. Mar 2010 B2
7697576 Maier et al. Apr 2010 B2
7760351 Cox et al. Jul 2010 B2
7820425 Schenk Oct 2010 B2
7826509 Belkin et al. Nov 2010 B2
7956328 Sundaram et al. Jun 2011 B2
7963399 Böhm et al. Jun 2011 B2
7997831 Gilbert et al. Aug 2011 B2
8032200 Tearney et al. Oct 2011 B2
8080422 Neas et al. Dec 2011 B2
8123044 Johnson et al. Feb 2012 B2
8149402 Rich Apr 2012 B2
8158122 Hampson et al. Apr 2012 B2
8173001 Quake et al. May 2012 B2
8174394 Ridder et al. May 2012 B2
8198092 Durack et al. Jun 2012 B2
8206987 Durack et al. Jun 2012 B2
8209987 Hautman et al. Jul 2012 B2
8210209 Gilbert et al. Jul 2012 B2
8277764 Gilbert et al. Oct 2012 B2
8388822 Quake et al. Mar 2013 B2
8408399 Böhm et al. Apr 2013 B2
8502148 Wagner et al. Aug 2013 B2
8529161 Gilbert et al. Sep 2013 B2
8563325 Bartsch et al. Oct 2013 B1
8567608 Deshpande et al. Oct 2013 B2
8569069 Durack Oct 2013 B2
8623295 Gilbert et al. Jan 2014 B2
8727131 Deshpande et al. May 2014 B2
8731860 Charles et al. May 2014 B2
8784012 Toner et al. Jul 2014 B2
8863962 Johnson et al. Oct 2014 B2
8941062 Wagner et al. Jan 2015 B2
8961904 Xia et al. Feb 2015 B2
8964184 Gilbert et al. Feb 2015 B2
8981298 Wagner et al. Mar 2015 B2
9000357 Mueth et al. Apr 2015 B2
9003869 Wagner et al. Apr 2015 B2
9011797 Gilbert et al. Apr 2015 B2
9109195 Zimmermann et al. Aug 2015 B2
9140690 Mueth et al. Sep 2015 B2
9255874 Sharpe et al. Feb 2016 B2
9260693 Johnson et al. Feb 2016 B2
9335247 Sharpe et al. May 2016 B2
9335295 Mueth et al. May 2016 B2
9339850 Deshpande et al. May 2016 B2
9365822 Seidel et al. Jun 2016 B2
9377400 Wagner et al. Jun 2016 B2
9446912 Gilbert et al. Sep 2016 B2
9485984 Burbank et al. Nov 2016 B2
9550215 Deshpande et al. Jan 2017 B2
9588100 Appleyard et al. Mar 2017 B2
9618442 Sharpe et al. Apr 2017 B2
9683922 Wagner et al. Jun 2017 B2
D791338 Morkos et al. Jul 2017 S
9752976 Gilbert et al. Sep 2017 B2
9781918 Zimmermann et al. Oct 2017 B2
9802767 Gilbert et al. Oct 2017 B2
9823252 Gilbert et al. Nov 2017 B2
9835552 Wagner Dec 2017 B2
D815754 Morkos et al. Apr 2018 S
9943847 Gilbert et al. Apr 2018 B2
9964968 Sharpe et al. May 2018 B2
10025322 Lofstrom et al. Jul 2018 B2
10029283 Deshpande et al. Jul 2018 B2
10175159 Wagner et al. Jan 2019 B2
10180388 Wagner Jan 2019 B2
10216144 Mueth et al. Feb 2019 B2
10315194 Akiyama et al. Jun 2019 B2
11187224 Xia et al. Nov 2021 B2
1119387 Wagner et al. Dec 2021 A1
11243494 Mueth et al. Feb 2022 B2
20020027649 Chudner Mar 2002 A1
20020042042 Fahy Apr 2002 A1
20020058332 Quake et al. May 2002 A1
20020106716 Leboeuf et al. Aug 2002 A1
20020115208 Mitchell et al. Aug 2002 A1
20020176069 Hansen et al. Nov 2002 A1
20020198928 Bukshpan et al. Dec 2002 A1
20030007894 Wang et al. Jan 2003 A1
20030032204 Walt et al. Feb 2003 A1
20030047676 Grier et al. Mar 2003 A1
20030054365 Xu et al. Mar 2003 A1
20030054558 Kurabayashi et al. Mar 2003 A1
20030068646 Singh et al. Apr 2003 A1
20030113709 Alivisatos et al. Jun 2003 A1
20030175944 Yang et al. Sep 2003 A1
20030186426 Brewer et al. Oct 2003 A1
20040043506 Haussecker et al. Mar 2004 A1
20040079893 Dietz et al. Apr 2004 A1
20040089798 Gruber et al. May 2004 A1
20040144648 Jacobson et al. Jul 2004 A1
20040161772 Bohm et al. Aug 2004 A1
20040166504 Rossier et al. Aug 2004 A1
20040206399 Heller et al. Oct 2004 A1
20040217297 Moses et al. Nov 2004 A1
20040229349 Daridon Nov 2004 A1
20040266022 Sundararajan et al. Dec 2004 A1
20050037471 Liu et al. Feb 2005 A1
20050061962 Mueth et al. Mar 2005 A1
20050103690 Kawano et al. May 2005 A1
20050112541 Durack et al. May 2005 A1
20050121604 Mueth et al. Jun 2005 A1
20050123450 Gilbert Jun 2005 A1
20050124869 Hefti et al. Jun 2005 A1
20050148085 Larsen Jul 2005 A1
20050153354 Gilmanshin Jul 2005 A1
20050190372 Dogariu Sep 2005 A1
20050196876 Chan et al. Sep 2005 A1
20050207940 Butler et al. Sep 2005 A1
20050207943 Puzey Sep 2005 A1
20060013270 Yumoto et al. Jan 2006 A1
20060035273 Quake et al. Feb 2006 A1
20060043301 Mantele et al. Mar 2006 A1
20060058167 Regusa et al. Mar 2006 A1
20060078888 Griffiths Apr 2006 A1
20060105453 Brenan et al. May 2006 A1
20060152707 Kanda Jul 2006 A1
20060170912 Mueth et al. Aug 2006 A1
20060252047 Ekstrom et al. Nov 2006 A1
20060257089 Mueth et al. Nov 2006 A1
20060263829 Evans et al. Nov 2006 A1
20070009386 Padmanabhan et al. Jan 2007 A1
20070078348 Holman Apr 2007 A1
20070114172 Mueth et al. May 2007 A1
20070128082 Yang et al. Jun 2007 A1
20070207551 Glensbjerg Sep 2007 A1
20070247620 Koo Oct 2007 A1
20070248958 Jovanovich et al. Oct 2007 A1
20070255362 Levinson Nov 2007 A1
20080003685 Goix et al. Jan 2008 A1
20080014574 Viator et al. Jan 2008 A1
20080069733 Maltezo et al. Mar 2008 A1
20080144037 Mueth et al. Jun 2008 A1
20080166188 Gilbert et al. Jul 2008 A1
20080195020 Cabuz et al. Aug 2008 A1
20080213821 Liu et al. Sep 2008 A1
20080248966 Hansen et al. Oct 2008 A1
20080261295 Butler et al. Oct 2008 A1
20080292555 Ye et al. Nov 2008 A1
20080299013 Trieu et al. Dec 2008 A1
20080309919 Birmingham et al. Dec 2008 A1
20080311005 Kim et al. Dec 2008 A1
20090029870 Ward et al. Jan 2009 A1
20090032449 Mueth et al. Feb 2009 A1
20090042241 Yu-Chong et al. Feb 2009 A1
20090051912 Salazar et al. Feb 2009 A1
20090114285 Hashimoto et al. May 2009 A1
20090125242 Choi et al. May 2009 A1
20090141279 Hillmer Jun 2009 A1
20090156932 Zharov Jun 2009 A1
20090170149 Viator et al. Jul 2009 A1
20090176271 Durack et al. Jul 2009 A1
20090201504 Ho et al. Aug 2009 A1
20090225319 Lee et al. Sep 2009 A1
20090281250 DeSimone et al. Nov 2009 A1
20090290156 Popescu et al. Nov 2009 A1
20100044570 McGill et al. Feb 2010 A1
20100068723 Jovanovich et al. Mar 2010 A1
20100079516 Nakazawa Apr 2010 A1
20100171954 Quake et al. Jul 2010 A1
20100216208 Mueth et al. Aug 2010 A1
20100248362 Durack et al. Sep 2010 A1
20100330693 Chapin et al. Dec 2010 A1
20110001963 Durack Jan 2011 A1
20110003303 Pagano et al. Jan 2011 A1
20110003324 Durack Jan 2011 A1
20110003325 Durack Jan 2011 A1
20110003330 Durack Jan 2011 A1
20110008764 Silva et al. Jan 2011 A1
20110008767 Durack Jan 2011 A1
20110008817 Durack Jan 2011 A1
20110008818 Durack Jan 2011 A1
20110075928 Jeong et al. Mar 2011 A1
20110076712 Gilligan et al. Mar 2011 A1
20110090500 Hu et al. Apr 2011 A1
20110190146 Boehm et al. Aug 2011 A1
20110223654 Holman et al. Sep 2011 A1
20110256523 Mendele et al. Oct 2011 A1
20110263747 Doyle et al. Oct 2011 A1
20110294139 Takeda Dec 2011 A1
20120009619 Gilbert et al. Jan 2012 A1
20120028366 Krager et al. Feb 2012 A1
20120033220 Kotidis et al. Feb 2012 A1
20120033697 Goyal et al. Feb 2012 A1
20120081709 Durack Apr 2012 A1
20120082362 Diem et al. Apr 2012 A1
20120107805 Neas et al. May 2012 A1
20120122084 Wagner et al. May 2012 A1
20120138152 Villarruel et al. Jun 2012 A1
20120183947 Mueth et al. Jul 2012 A1
20120196356 Wagner et al. Aug 2012 A1
20120199741 Wagner et al. Aug 2012 A1
20120199742 Wagner et al. Aug 2012 A1
20120202237 Sedoglavich et al. Aug 2012 A1
20120202277 Wagner et al. Aug 2012 A1
20120202278 Wagner et al. Aug 2012 A1
20120204628 Wagner et al. Aug 2012 A1
20120225474 Wagner et al. Sep 2012 A1
20120225475 Wagner et al. Sep 2012 A1
20120273054 Lou et al. Nov 2012 A1
20120287419 Sharpe et al. Nov 2012 A1
20120307244 Lou et al. Nov 2012 A1
20130121877 Ono May 2013 A1
20130164773 Bardell et al. Jun 2013 A1
20130200277 Li et al. Aug 2013 A1
20130224843 Evans et al. Aug 2013 A1
20130252237 Wagner Sep 2013 A1
20130295602 Fowler Nov 2013 A1
20130313170 Bohm et al. Nov 2013 A1
20140033808 Ding et al. Feb 2014 A1
20140050540 Gilbert et al. Feb 2014 A1
20140091014 Wagner et al. Apr 2014 A1
20140224710 Di Carlo et al. Aug 2014 A1
20140273192 Sharpe Sep 2014 A1
20140287243 Weber et al. Sep 2014 A1
20140318645 Koksal Oct 2014 A1
20140339446 Yamamoto et al. Nov 2014 A1
20140361148 Popescu et al. Dec 2014 A1
20150064694 Sadri Mar 2015 A1
20150114093 Appleyard et al. Apr 2015 A1
20150192511 Wagner et al. Jul 2015 A1
20150198517 Simpson Jul 2015 A1
20150276588 Marshall et al. Oct 2015 A1
20160004060 Simpson et al. Jan 2016 A1
20160123858 Kapur et al. May 2016 A1
20160199835 Tachibana et al. Jul 2016 A1
20170016813 Wagner et al. Jan 2017 A1
20170333902 Masaeli Nov 2017 A1
20180266937 de Wagenaar et al. Sep 2018 A1
20190025212 Evans Jan 2019 A1
20190040356 Durack et al. Feb 2019 A1
20190160439 Muto et al. May 2019 A1
20190187044 Appleyard et al. Jun 2019 A1
20190390164 Morjal et al. Dec 2019 A1
20220026341 Appleyard et al. Jan 2022 A1
Foreign Referenced Citations (98)
Number Date Country
1341328 Dec 2001 CA
1482369 Mar 2004 CN
1886315 Dec 2006 CN
101189504 May 2008 CN
0057907 Aug 1982 EP
0282994 Sep 1988 EP
0679325 Jul 1994 EP
0471758 Sep 1996 EP
2798557 Mar 2001 FR
502971 May 1939 GB
2507959 May 2014 GB
57-131451 Aug 1982 JP
58090513 May 1983 JP
S 64-26125 Jan 1989 JP
64074451 Mar 1989 JP
02105041 Apr 1990 JP
03297385 Dec 1991 JP
H0526799 Feb 1993 JP
06265452 Sep 1994 JP
06327494 Nov 1994 JP
07024309 Jan 1995 JP
07286953 Oct 1995 JP
2552582 Nov 1996 JP
H10512952 Dec 1998 JP
H11508182 Jul 1999 JP
2000146819 May 2000 JP
2000512541 Sep 2000 JP
2001504936 Apr 2001 JP
2002503334 Jan 2002 JP
2002153260 May 2002 JP
2003106980 Apr 2003 JP
2003515738 May 2003 JP
2004093553 Mar 2004 JP
2005502482 Jan 2005 JP
2005530986 Oct 2005 JP
2006524054 Oct 2006 JP
2007-514522 Jun 2007 JP
2007148981 Jun 2007 JP
2007514522 Jun 2007 JP
2007515936 Jun 2007 JP
2008533440 Aug 2008 JP
2008261295 Oct 2008 JP
2009085872 Apr 2009 JP
2009115672 May 2009 JP
2010117197 May 2010 JP
2010151777 Jul 2010 JP
2010190680 Sep 2010 JP
2011145185 Jul 2011 JP
2014503195 Feb 2014 JP
WO9622521 Jul 1996 WO
WO9700442 Jan 1997 WO
WO9739338 Oct 1997 WO
WO9747390 Dec 1997 WO
WO9810267 Mar 1998 WO
WO9939223 Aug 1999 WO
WO20000070080 Nov 2000 WO
WO0118400 Mar 2001 WO
WO0131315 May 2001 WO
WO2001040766 Jun 2001 WO
WO0185913 Nov 2001 WO
WO200241906 May 2002 WO
WO2002081183 Oct 2002 WO
WO02087792 Nov 2002 WO
WO03024163 Mar 2003 WO
WO03062867 Jul 2003 WO
WO03078065 Sep 2003 WO
WO2003078065 Sep 2003 WO
WO2004012133 Feb 2004 WO
WO2004029221 Apr 2004 WO
WO2004043506 May 2004 WO
WO2004088283 Oct 2004 WO
WO20040088283 Oct 2004 WO
WO2005023391 Mar 2005 WO
WO2005075629 Aug 2005 WO
WO20050075629 Aug 2005 WO
WO2006119806 Nov 2006 WO
WO20060119806 Nov 2006 WO
WO2007008495 Jan 2007 WO
WO2007133710 Nov 2007 WO
WO2008114458 Sep 2008 WO
2008130977 Oct 2008 WO
WO2008126064 Oct 2008 WO
WO2008130977 Oct 2008 WO
WO2009032449 Mar 2009 WO
WO2009134395 Nov 2009 WO
WO2010129441 Nov 2010 WO
WO2012068287 May 2012 WO
WO2012112641 Aug 2012 WO
WO20120112641 Aug 2012 WO
WO20130018273 Feb 2013 WO
WO2013173446 Nov 2013 WO
WO2005037471 Sep 2014 WO
WO2015063552 May 2015 WO
2017201546 Nov 2017 WO
WO2018047011 Mar 2018 WO
WO2018047011 May 2018 WO
WO2018151680 Aug 2018 WO
WO2020092321 May 2020 WO
Non-Patent Literature Citations (216)
Entry
Di Carlo et al. “Equilibrium Separation and Filtration of Particles Using Differential Inertial Focusing” Anal. Chem. 2008, 80, 2204-2211 (Year: 2008).
“Hydraulic Diameter”, Neutrium, Apr. 1, 2012, https://neutrium.net/fluid-flow/hydraulic-diameter/ (Year: 2012).
Gossett et al. “Particle Focusing Mechanisms in Curving Confined Flows” Anal. Chem. 2009, 81, 8459-8465 (Year: 2009).
Di Carlo et al. “Continuous inertial focusing, ordering, and separation of particles in microchannels” PNAS Nov. 27, 2007 vol. 104 No. 48 18893 (Year: 2007).
Di Carlo, D. “Inertial microfluidics” Lab Chip, 2009, 9, 3038-3046 (Year: 2009).
International Searching Authority, “International Search Report and Written Opinion,” issued in connection with International Patent Application No. PCT/US2019/033557, dated Jul. 11, 2019, 13 pages.
Japan Patent Office; “Notice of Reasons for Refusal,” issued in connection with Japanese Patent Application No. 2019-088655, dated Feb. 18, 2020, 5 pages.
Sell, “Cellular Origin of Cancer: Dedifferentiation or Stem Cell Maturation Arrest?”, Environmental Health Perspectives, vol. 101, Suppl. 5, 1993, p. 15-26.
Shapiro et al., “Pratical Flow Cytometry,” Fourth Edition, New Jersey: John W. Wiley & Sons, 2003, 733 pages.
Sharpe et al.,“Advances in Flow Cytometry for Sperm Sexing,” Theriogenology, vol. 71, 2009, pp. 4-10.
Short, “Raman Spectroscopy Detects Biochemical Changes Due to Proliferation in Mammalian Cell Cultures,” Biophysical Journal, vol. 88, Jun. 2005, pp. 427 4-4288.
USPTO, “Non-Final Office Action,” issued in connection with U.S. Appl. No. 15/226,899, dated Apr. 12, 2018, 14 pages.
USPTO, “Notice of Allowance,” issued in connection with U.S. Appl. No. 15/226,899, dated Aug. 23, 2018, 5 pages.
USPTO, “Notice of Allowance,” issued in connection with U.S. Appl. No. 15/226,899, dated Sep. 20, 2018, 6 pages.
USPTO, “Final Office Action,” issued in connection with U.S. Appl. No. 15/174,681, dated Jan. 2, 2018, 15 pages.
USPTO, “Final Office Action,” issued in connection with U.S. Appl. No. 15/174,681, dated Sep. 14, 2018, 17 pages.
USPTO, “Non-Final Office Action,” issued in connection with U.S. Appl. No. 15/174,681, dated May 4, 2017, 13 pages.
USPTO, “Non-Final Office Action,” issued in connection with US Patent Application 15/174,681, dated Apr. 5, 2018, 16 pages.
USPTO, “Notice of Allowance,” issued in connection with U.S. Appl. No. 15/174,681, dated Nov. 27, 2018, 10 pages.
USPTO, “Final Office Action,” issued in connection with U.S. Appl. No. 13/298,148, dated Oct. 18, 2013, 46 pages.
USPTO, “Non-Final Office Action,” issued in connection with U.S. Appl. No. 13/298,148, dated Feb. 5, 2013, 66 pages.
USPTO, “Notice of Allowance,” issued in connection with U.S. Appl. No. 13/298,148, dated Sep. 19, 2014, 9 pages.
USPTO, “Office Action,” issued in connection with U.S. Appl. No. 13/298,148, dated Sep. 28, 2012, 5 pages.
USPTO, “Final Office Action,” issued in connection with U.S. Appl. No. 13/894,831, dated Sep. 10, 2015, 11 pages.
USPTO, “Final Office Action,” issued in connection with U.S. Appl. No. 13/894,831, dated Jun. 15, 2017, 19 pages.
USPTO, “Non-Final Office Action,” issued in connection with U.S. Appl. No. 13/894,831, dated Dec. 23, 2014, 11 pages.
USPTO, “Non-Final Office Action,” issued in connection with U.S. Appl. No. 13/894,831, dated Oct. 5, 2016, 17 pages.
USPTO, “Notice of Allowance,” issued in connection with U.S. Appl. No. 13/894,831, dated Apr. 1, 2016, 8 pages.
USPTO, “Notice of Allowance,” issued in connection with U.S. Appl. No. 13/894,831, dated Sep. 5, 2017, 9 pages.
Wang et al., Detection of endogenous biomolecules in Barrett's esophagus by Fourier transform infrared spectroscopy, PNAS, vol. 104, No. 40, Oct. 2, 2007, p. 15864-15869.
Webster, Merriam, “Definition of “successive,” Merriam Webster's Online Dictionary, accessed at http://www.merriamwebster com/dictionary/successive,” Jun. 18, 2013, 1 page.
Weida et al., “Quantum Cascade Laser Based Replacement for FTIR Microscopy,” http://www.daylightsolutions. :: om/assets/003/5308.pdf, accessed online Aug. 2, 2012, 7 pages.
International Bureau, “International Preliminary Report on Patentability,” issued in connection with International Patent Application No. PCT/IB2017/001289, dated Mar. 21, 2019, 12 pages.
International Search Report and Written Opinion for Application Serial No. PCT/IP2017/001289, dated Apr. 3, 2018, 21 pages.
Mehrnoush Malek et al: flowDensity: reproducing manual gating of flow cytometry data by automated density-based cell population identification11 , BIOINFORMATICS., vol. 31, No. 4, Oct. 16, 2014 (Oct. 16, 2014), pp. 306-607.
International Search Report and Written Opinion for Application Serial No. PCT/IB2018/001641, dated Jun. 25, 2020 4 pages.
China Patent Office, “The Fourth Office Action,” issued in connection with China Patent Application No. 201480071952.0, dated Jan. 3, 2021, 25 pages.
Japan Patent Office, “Notice of Reasons for Refusal,” issued in connection with Japan Patent Application No. 2019-088655, dated Oct. 13, 2020, 5 pages.
Johnson LA et al., Flow sorting of X and Y chromosome-bearing spermatozoa into two populations, Gamete Research. Jan. 1987. 16(1):1-9. (Johnson 1987).
Paape et al., Flow Cytometry: A Versatile Tool for Studies on Cells From Domestic Animals, National Cytometry Symposium, Abstract Only, Dec. 14, 1997, https://www.ars.usda.gov/research/publications/publication/?seqNo115=86408.
Keij, J.F. et al., “High-Speed Photodamage Cell Selection Using a Frequency-Doubled Argon Ion Laser.” Cytometry 19 (1995): 209-216. (Keij 1995).
Keij, J.F., “Introduction to High-Speed Flow Sorting.” Flow and Image Cytometry. Series H: Cell Biology, 95 (1996) 213-227. (Keij 1996).
Johnson LA, Welch GR, Rens W. “The Beltsville sperm sexing technology: high-speed sperm sorting gives improved sperm output for in vitro fertilization and AI.” J Anim Sci 1999. 77:213-220.
Counterclaim Defendants Abs Global Inc.'s and Genus PLC's Invalidity Contentions. Abs Global, Inc., v.Inguran, LLC D/B/A Sexing Technologies and. XY, LLC v. Genus PLC. Case No. 14-cv-503 United States District Court for the Western District of Wisconsin; pp. 1, 43-114, and 168-177.
ABS Global, Inc. And Genus PLC's Renewed Motion For Judgment As A Matter Of Law That The Asserted Claims Of The '987 Patent Are Invalid For Lack Of Enablement And, In The Alternative, For A New Trial. ABS Global, Inc. v. Inguran, LLC & XY, LLC v. Genus PLC. Case: 3:14-cv-00503-wmc. Filed on Jul. 3, 2020.
Brief in Support of ABS Global, Inc. And Genus PLC's Motion for Judgment as A Matter of Law That the Asserted Claims Of The '987 Patent Are Not Enabled. INGURAN, LLC d/b/a STGENETICS, XY, LLC, and CYTONOME/ST, LLC, Plaintiffs/Counterclaim-Defendants, v.ABS GLOBAL, INC., GENUS PLC, and PREMIUM GENETICS (UK) LTD, Defendants/Counterclaim-Plaintiffs. Case: 3:17-cv-00446-wmc. Filed Sep. 6, 2019.
ABS Global, Inc. And Genus Plc Renewed Motion for Judgment As A Matter Of Law That The Asserted Claims Of The 987 Patent Are Invalid For Lack Of Enablement And, In The Alternative, For A New Trial. INGURAN, LLC d/b/a STGENETICS, XY, LLC, and CYTONOME/ST, LLC, Plaintiffs/Counterclaim-Defendants, v.ABS GLOBAL, INC., 3ENUS PLC, and PREMIUM GENETICS (UK) LTD, Defendants/Counterclaim-Plaintiffs. Case: 3:17-cv-00446-wmc. filed Jul. 3, 2020.
ABS Global, Inc. And Genus PLC's Reply In Support Of Their Renewed Motion For Judgment As A Matter Of Law That The Asserted Claims Of The '987 Patent Are Invalid For Lack Of Enablement And, In The Alternative, For A New Trial. INGURAN, LLC d/b/a STGENETICS, XY, LLC, and CYTONOME/ST, LLC, Plaintiffs/Counterclaim-Defendants, v. ABS GLOBAL, INC., GENUS PLC, and PREMIUM GENETICS (UK) LTD, Defendants/Counterclaim-Plaintiffs. Case: :17-cv-00446-wmc. Filed Aug. 17, 2020.
ABS GLOBAL, INC. and GENUS PLC's Motion For Judgment As A Matter Of Law That The Asserted Claims Of The 987 And '092 Patents Are Invalid. ABS GLOBAL, INC., Plaintiff/Counterclaim Defendant, v. INGURAN, LLC d/b/a SEXING TECHNOLOGIES, Defendant/Counterclaim Plaintiff, and XY, LLC, Intervenor-Defendant/Counterclaim Plaintiff, v. GENUS PLC, Counterclaim Defendant. Case: 3:14-cv-00503-wmc. Filed Aug. 9, 2016.
ABS GLOBAL, INC. and GENUS PLC's Rule 50(8) Motion For Judgment As A Matter Of Law And Rule 59 Motion For A New Trial. ABS GLOBAL, INC., Plaintiff/Counterclaim Defendant, v. INGURAN, LLC d/b/a SEXING TECHNOLOGIES, Defendant/Counterclaim Plaintiff, and XY, LLC, Intervenor-Defendant/Counterclaim Plaintiff, v. 3ENUS PLC, Counterclaim Defendant. Case: 3:14-cv-00503-wmc. Filed Sep. 2, 2016.
Opinion and Order of the United States District Court For The Western District Of Wisconsin. Plaintiff/Counterclaim Defendant, v. INGURAN, LLC d/b/a SEXING TECHNOLOGIES, Defendant/Counterclaim Plaintiff, and XY, LLC, Intervenor-Defendant/Counterclaim Plaintiff, v. GENUS PLC, Counterclaim Defendant. Case: 3:14-cv-00503-wmc. riled Mar. 31, 2017.
Appeal from the United States District Court for the Western District of Wisconsin. No. 14-CV-503. ABS GLOBAL, NC., Plaintiff/Counterclaim Defendant-Appellant, and GENUS PLC, Counterclaim Defendant-Appellant, v. INGURAN, LLC, doing business as SEXING TECHNOLOGIES, Defendant/Counterclaim Plaintiff-Appellee, and XY, LLC, Intervening Defendant/Counterclaim Plaintiff-Appellee. Case: 3:14-cv-00503-wmc. Filed: Mar. 8, 2019.
Judge's Opinion & Order in Case No. 14-cv-503-wmc. Plaintiff/Counterclaim Defendant, v. INGURAN, LLC di b/a Sexing TECHNOLOGIES, Defendant/Counterclaim Plaintiff, and XY, LLC, Intervenor-Defendant/Counterclaim Plaintiff, v. GENUS PLC, Counterclaim Defendant. Case: 3:14-cv-00503-wmc. Filed Jul. 21, 2016.
ABS Global Inc. and GENUS PLC's Reply in Support of Their Motion for Claim Construction and Partial Summary Judgment, ABS Global, Inc. v. Inguran, LLC d/b/a Sexing Technologies, Case No. 14-cv-503, United States District Court for the Western District of Wisconsin. Mar. 7, 2016.
USPTO, “Final Office Action,” issued in connection with U.S. Appl. No. 16/741,608, dated Oct. 21, 2021, 11 pages.
Trial Transcript, Sep. 5, 2019 (a.m.); ABS Global, Inc. v. Inguran, LLC d/b/a Sexing Technologies, Case Nos. 17-cv-446 and 14-cv-503, United States District Court for the Western District of Wisconsin.
Brief in Support of ABS Global, Inc. and Genus PLC's Rule 50(8) Motion for Judgment as a Matter of Law and Rule 59 Motion for a New Trial, ABS Global, Inc. v. Inguran, LLC d/b/a Sexing Technologies, Case No. 14-cv-503, United States District Court for the Western District of Wisconsin. Filed Sep. 2, 2016.
Inguran, LLC and XY, LLC's Response To ABS Global, Inc. and Genus PLC's Rule 50(8) Motion Fof Judgment as a Matter of Law and Rule 59 Motion for New Trial, pp. 9-28, 33-36, 73-74. Filed Sep. 23, 2016.
ST's Response To ABS's Renewed Motion for Judgment as a Matter of Law That the Asserted Claims of The '987 Patent Are Invalid for Lack of Enablement and, in the Alternative, for a New Trial, ABS Global, Inc. v. Inguran, LLC d/b/a Sexing Technologies, Case No. 14-cv-503, United States District Court for the Western District of Wisconsin. Filed: Jul. 24, 2020.
Clinical Laboratory Instruments and In Vitro Diagnostic Reagents, Personnel Department of the State Food and Drug Administration, et al., pp. 17-21, China Medical Science and Technology Publishing House, Oct. 31, 2010).
Dicarlo “Continuous inertial focusing, ordering, and separation of particles in microchannels” BioMEMS Resource Center, Center for Engineering in Medicine and Surgical Services, Massachusetts General Hospital, Nov. 27, 2007, PNAS, 18892-18897, vol. 104, No. 48.
Dicarlo “Equilibrium Separation and Filtration of Particles Using Differential Inertial Focusing” BioMEMS Resource Center, Center for Engineering in Medicine and Surgical Services, Massachusetts General Hospital, Anal Chem 2008, 8, 2204-2211.
Dicarlo “Inertial Microfluidics: High-Throughput Focusing and Separation of Cells and Particles” BioMEMS Resource Center, Center for Engineering in Medicine, Massachusetts General Hospital, Twelfth International Conference on Miniaturized Systems for Chemistry and Life Sciences, Oct. 12-16, 2008, San Diego, California, USA.
Altendorf et al., “Results Obtained Using a Prototype Microfluidics-Based Hematology Analyzer,” in Proceedings of the microTAS 1998 Symposium, 73-76 (Oct. 1998).
Nieuwenhuis et al., “Particle-Shape Sensing-Elements for Integrated Flow Cytometer,” in Proceedings of the microTAS 2001 Symposium, 357-358 (Oct. 21, 2001).
Nieuwenhuis et al. “Virtual Flow Channel: A Novel Micro-fluidics System with Orthogonal, Dynamic Control of Sample Flow Dimensions,” in Proceedings of the microTAS 2002 Symposium, vol. 1, 103-105 (Nov. 3, 2002).
Nieuwenhuis, J., et al. “Integrated flow-cells for novel adjustable sheath flows.” Lab Chip, 2003, 3, 56-61 (Mar. 2003.
Shoji, S., et al. “Design and fabrication of micromachined chemical/biochemical systems.” RIKEN Rev., vol. 36, pp. 8-11, 2001.
Lin, C., et al. “A Novel Microflow Cytometer with 3-dimensional Focusing Utilizing Dielectrophoretic and Hydrodynamic Forces.” The Sixteenth Annual International Conference on Micro Electro Mechanical Systems, 2003. MEMS-03 Kyoto. IEEE, Kyoto, Japan, 2003, pp. 439-442.
Miyake et al., “A Development of Micro Sheath Flow Chamber,” in Proceedings of the IEEE Micro Electro Mechanical Systems Workshop 1991, 265-270 (Jan. 1991).
Tashiro et al., “Design and Simulation of Particles and Biomolecules Handling Micro Flow Cells with Three-Dimensional Sheath Flow,” in Proceedings of the microTAS 2000 Symposium, 209-212 (May 14, 2000).
Weigl, B. et al. “Design and Rapid Prototyping of Thin-Film Laminate-Based Microfluidic Devices.” Biomedical Microdevices, 3:4, pp. 267-274, 2001.
Blankenstein, G. et al. “Modular concept of a laboratory on a chip for chemical and biochemical analysis.” Biosensors & Bioelectronics, vol. 13. No. 3-4, pp. 427-438, 1998.
Shapiro, Practical Flow Cytometry, 15-17, 133-135 (3rd ed. 1995).
Shapiro, Practical Flow Cytometry, 55-57, 166-169 (4th ed. 2003).
International Search Report for PCT Patent Application No. PCT/IB2014/001425 dated Apr. 28, 2015.
Herweijer, H. et al., “High Speed Photodamage Cell Selection Using Bromodeoxyuridine/Hoechst 33342 Photosensitized Cell Killing”, Radiobiological Institute TNO, Rotterdam, The Netherlands, Jun. 1, 1987.
Johnson, L.A., et al., “Sex Preselection: High-Speed Flow Cytometric Sorting of X and Y Sperm for Maximum Efficiency” U.S. Dept. of Agriculture, Beltsville, MD, Sep. 23, 1999.
Bazyer H., et al., “Views and Reviews—Compact 151W Green Laser with U-Type Resonator for Prostate Surgery”, Optics & Laser Technology, vol. 47, Apr. 27, 2013, 237-241.
Keij, J. et al., “High-Speed Photodamage Cell Sorting: An Evaluation of the ZAPPER Prototype”, Methods in Cell Biology, 1994; pp. 371-386, vol. 42, Chapter 22, Academic Press, Inc.
International Search Report and Written Opinion dated Mar. 7, 2014 in connection with PCT/US2013/050669.
Kachel, V, et al., “Uniform Lateral Orientation, caused by Flow Forces, of Flat Particles in Flow-Through Systems”, The Journal of Histochemistry and Cytochemistry, vol. 25, No. 7, pp. 774-780, 1977.
Notice of Allowance issued in U.S. Appl. No. 13/943,322 dated Sep. 12, 2014.
Fulwler, M., “Hydrodynamic Orientation of Cells”, The Journal of Histochemistry and Cytochemistry, vol. 25, No. 7, pp. 781-783, 1977.
Khodjakov A., et al., “A Synergy of Technologies: Combining Laser Microsurgery with Green Fluorescent Protein Tagging”, Cell Motility and the Cytoskeleton 38:311-317 (1997), Division of Molecular Medicine and Department of Biomedical Sciences, Albany, New York.
Canadian Office Action, Application No. 2,929,275, dated May 4, 2020, 8 pages.
Australian Office Action, Application No. 2019202882, dated Mar. 26, 2020, 3 pages.
Brazilian Office Action, Application No. BR122017012966-0, dated Jun. 2, 2020, 6 pages.
Japan Patent Office, “Reconsideration Report by Examiner before Appeal,” issued in connection with Japanese Patent Application No. 2016-551082, dated Jul. 12, 2019, 17 pages. 20090114285.
Intellectual Property India, “Examination Report,” issued in connection with Indian Patent Application No. 3425/DELNP/2015, dated Jan. 20, 2020, 6 pages.
European Patent Office, “Extended European Search Report,” issued in connection with patent application No. 19182993.6, dated Oct. 21, 2019, 11 pages.
China National Intellectual Property Administration, “Second Office Action,” issued in connection with Chinese Patent Application No. 201480071952.0, dated Nov. 26, 2018, 34 pages.
China National Intellectual Property Administration, “Decision of Rejection,” issued in connection with Chinese Patent Application No. 201480071952.0, dated Mar. 4, 2019, 19 pages.
IP Australia, “Examination Report No. 1 for Standard Patent Application,” issued in connection with Australian Patent Application No. 2014343391, dated Sep. 4, 2018, 3 pages.
International Preliminary Report on Patentability, issued in connection with application PCT/IB/001425, dated May 3, 2016, 11 pages.
Japan Patent Office, “Non Final Notice of Reasons for Rejection,” issued in connection with Japanese Patent Application No. 2016-551082, dated Apr. 24, 2018, 5 pages.
New Zealand IP Office, “First Examination Report,” issued in connection with New Zealand Patent Application No. 720575, dated Sep. 9, 2016, 5 pages.
New Zealand IP Office, “Further Examination Report,” issued in connection with New Zealand Patent Application No. 720575, dated Apr. 28, 2017, 3 pages.
State Intellectual Property Office of People's Republic of China, “Notification of First Office Action,” issued in connection with Chinese Patent Application No. 201480071952.0, dated Mar. 16, 2018, 31 pages.
New Zealand IP Office, “Further Examination Report,” issued in connection with New Zealand Patent Application No. 735496, dated Aug. 31, 2018, 2 pages.
Drobnis et al., Cold Shock Damage is due to Lipid Phase Transitions in Cell Membranes: A Demonstration Using Sperm as a Model, The Journal of Experimental Zoology, 1993, 265:432-437.
Way et al., Comparison of four staining methods for evaluating acrosome status and viability of ejaculated and cauda epididymal bull spermatozoa, Theriogenology, 1995, 43(8): 1301-1316.
Marian et al., Hypo-osmotic Shock Induces an Osmolality-dependent Permeabilization and Structural Changes in the Membrane of Carp Sperm, 1993, 41(2):291-297.
Molecular Probes Inc., Product Information, Influx Pinocy1ic Cell-Loading Reagent (1-14402), Revised Feb. 1, 2001, 1-7.
Parks, Processing and Handling Bull Semen for Artificial Insemination—Don't Add Insult to Injury!, Department of Animal Sciences, Cornell University, 2001, retrieved on May 29, 2015, retrieved from the internet: http://www/ansci.cornell.edu/bullsemen.pdf.
Mammal (Online Datasheet), Wikipedia, 2003, retrieved on Aug. 13, 2018, retrieved from internet: http://web.archive.org/web/20031230110838/hllps://en.wikipedia.org/wiki/Mammal.
International Searching Authority, “International Search Report and Written Opinion,” issued in connection with International Patent Application No. PCT/IB2016/000295, dated Oct. 14, 2016, 19 pages.
International Bureau, “International Preliminary Report on Patentability,” issued in connection with International Patent Application No. PCT/IB2016/000295, dated Aug. 31, 2017, 14 pages.
Japan Patent Office, “Office Action,” issued in connection with Japanese Patent Application No. 2017-543990, dated Jul. 31, 2019, 23 pages.
Al-Holy et al., “The Use of Fourier Transform Infrared Spectroscopy to Differentiate Escherichia coli O157:H7 from Other Bacteria Inoculated Into Apple Juice,” Food Microbiology, vol. 23, 2006, 162-168.
Alberts et al., “Molecular Biology of the Cell, 5th edition,” New York: Garland Science, 2008, p. 1293.
Barcot et al., “Investigation of Spermatozoa and Seminal Plasma by Fourier Transform Infrared Spectroscopy,” Applied Spectroscopy, vol. 61, No. 3, Mar. 2007, pp. 309-313.
Bassan et al; “Reflection Contributions to the Dispersion Artefact in FIIR Spectra of Single Biological Cells,” Analyst, vol. 134, Apr. 9, 2009, pp. 1171-1175.
Bassan et al; “Resonant Mie Scattering in Infrared Spectrascopy of Biological Materials—Understanding the Dispersion Artefact,” Analyst, vol. 134, 2009, pp. 1586-1593.
Bassan et al; “Resonant Mie Scattering {RMieS) Correction of Infrared Spectra From Highly Scattering Biological Samples,” Analyst, vol. 135, No. 2, Feb. 2010, pp. 268-277.
Belkin et al.; “Intra-Cavity Absorption Spectroscopy with Narrow-Ridge Microfluidic Quantum Cascade Lasers,” Applies Express, vol. 15, No. 18, Sep. 3, 2007, pp. 11262-11271.
Boustany et al.; “Microscopic Imaging and Spectroscopy with Scattered Light,” Annual Review of Biomedical Engineering, vol. 12, 2010, pp. 285-314.
Chan et al.; “Nondestructive Identification of Individual Leukemia Cells by Laser Trapping Raman Spectroscopy,” Analytical Chemistry, vol. 80, No. 6, Mar. 15, 2008, 8 pages.
Chan et al.; “Label-Free Biochemical Characterization of Stem Cells Using Vibrational Spectroscopy,” Journal of Biophotonics vol. 2, No. 11, Aug. 5, 2009, pp. 656-668.
Chan et al.; “Label-Free Separation of Human Embryonic Stem Cells {hESCs) and their Cardiac Derivatives using Raman Spectroscopy,” Lawrence Livermore Journal, LLNL-JRNL-406938, Sep. 11, 2008, 30 pages.
Chen et al,; “Synchrotron Infrared Measurements of Protein Phosphorylation in Living Single PC12 Cells during Neuronal Differentiation,” Analytical Chemistry, vol. 84, 2012, pp. 4118-4125.
Cheng et al., “Laser-Scanning Coherent Anti-Strokes Raman Scattering Microscopy and Applications to Cell Biology,” Biophysical Journal, vol. 83, Jul. 2002, pp. 502-509.
Cho et al., “Passively Driven Integrated Microfluidic System for Separation of Motile Sperm,” Analytical Chemistry, vol. 75, Apr. 1, 2003, Abstract.
Cho et al., A Microfluidic Device For Separating Motile Sperm From Nonmotile Sperm Via Inter-Streamline.
Cleary et al., “Infrared Surface Plasmon Resonance Biosensor,” OSA Biomed, Miami, Florida, Apr. 2010, 6 pages.
Dousseau et al., “On the Spectral Subtraction of Water from the FT-IR Spectra of Aqueous Solutions of Proteins,” Applied Spectroscopy, vol. 43, No. 3, 1989, pp. 538-542.
Downes et al., “Optical Spectroscopy for Noninvasive Monitoring of Stem Cell Differentation,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 101864, 2010, 10 pages.
Ege, “Organic Chemistry: Structure and Reactivity,” Fifth Edition, Boston, MA, Houghton Mifflin Company, 2004, pp. 453-457.
European Patent Office, “Extended European Search Report,” issued in connection with European Patent Application No. 11841869.8, dated Feb. 15, 2018, 9 pages.
Fu et al., “A Microfabricated Fluorescence-Activated Cell Sorter,” Nature Biotechnology, vol. 17, Nov. 1999, pp. 1109-1111.
Green et al., “Flow Cytometric Determination of Size and Complex Refractive Index for Marine Particles: Comparison with Independent and Bulk Estimates,” Applied Optics, vol. 42, No. 3, Jan. 20, 2003, pp. 526-541.
Harvey et al., “Discrimination of Prostate Cancer Cells by Reflection Mode FTIR Photoacoustic Spectroscopy,” The Analyst, vol. 132, 2007, pp. 292-295.
Herzenberg et al., “Fluorescence-activated Cell Sorting,” Scientific American, vol. 234, Mar. 1976, pp. 108-117.
Holman et al., “Synchrotron-Based FTIR Spectromicroscopy: Cytotoxicity and Heating Considerations,” Journal of Biological Physics, vol. 29, 2003, pp. 275-286.
Holman et al., “IR Spectroscopic Characteristics of Cell Cycle and Cell Death Probed by Synchrotron Radiation Based Fourier Transform IR Spectromicroscopy,” Biopolymers (Biospectroscopy) vol. 57, 2000, pp. 329-335.
Holman et al., “Tracking Chemical Changes in a Live Cell: Biomedical Applications of SR-FTIR Spectromicroscopy,” Lawrence Berkeley National Laboratory, http://escholarship.org/uc/item/9k185794, Berkeley, CA Jul. 25, 2002, 34 pages.
Huser et al., “Raman Spectroscopy of DNA Packaging in Individual Human Sperm Cells Distinguishes Normal From Abnormal Cells,” Journal of Biophotonics, vol. 2, No. 5, 2009, pp. 322-332.
Intel, “Intel C-bank Tunable Laser, Performance and Design,” White Paper, May 2003, 14 pages.
International Searching Authority, “International Search Report and Written Opinion,” International Patent Application No. PCT/US2013/41123, dated Aug. 19, 2013, 12 pages.
International Search Authority, “International Preliminary Report on Patentability,” International Patent Application No. PCT/US2011/061046, dated May 30, 2013, 7 pages.
International Searching Authority, “International Preliminary Report on Patentability,” International Patent Application No. PCT/US2013/041123, dated Nov. 18, 2014, 7 pages.
Japan Patent Office, “Office Action,” issued in connection with Japanese Patent Application No. 2013-539983, dated Jul. 8, 2015, 6 pages.
Japan Patent Office, “Office Action,” issued in connection with Japanese Patent Application No. 2013-539983, dated Jul. 2, 2016, 6 pages.
Japan Patent Office, “Office Action,” issued in connection with Japanese Patent Application No. 2016-198323, dated Oct. 2, 2017, 3 pages.
Japan Patent Office, “Office Action,” issued in connection with Japanese Patent Application No. 2016-198323, dated Jul. 25, 2018, 9 pages.
Lee et al., “DFB Quantum Cascade Laser Arrays,” IEEE Journal of Quantum Electronics, vol. 45, No. 5, May 9, pp. 554-565.
Ibbus et al., “Incidence of Chromosome Aberrations in Mammalian Sperm Stained with Hoechst 33342 and UV-aser Irradiated During Flow Sorting,” Mutation Research, vol. 182, 1987, pp. 265-274.
Malone, Jr., “Infrared Microspectroscopy: A Study of the Single Isolated Bread Yeast Cell,” Thesis, The Ohio State University, 2010, 162 pages.
Meister et al., “Confocal Raman Microspectroscopy as an Analytical Tool to Assess the Mitochondral Status in Human Spermatozoa,” Analyst, vol. 135, 2010, pp. 1370-1374.
Miyamoto et al., “Label-free Detection and Classification of DNA by Surface Vibration Spectroscopy in Conjugation with Electrophoresis,” Applied Physics Letters, vol. 86, No. 053902, 2005, 3 pages.
Mohlenhoff et al., “Mie-Type Scattering and Non-Beer-Lambert Absorption Behavior of Human Cells in Infared Microspectroscopy,” Biophysical Journal, vol. 88, May 2005, pp. 3635-3640.
Montag et al., “Laser-induced Immobilization and Plasma Membrane Permeabilization in Human Spermatozoa,” Human Reproduction, vol. 15, No. 4, 2000, pp. 846-852.
Mourant et al., “Methods for Measuring the Infrared Spectra of Biological Cells,” Physics in Medicine and Biology, vol. 48, 2003, pp. 243-257.
Van Munster, “Interferometry in Flow to Sort Unstained X-and Y-Chromosome-Bearing Bull Spermatozoa,” Cytometry, vol. 47, 2002, pp. 192-199.
Rajagopalan et al., “Aneuploidy and Cancer,” Nature, vol. 432, Nov. 2004, pp. 338-341.
Ropcke et al., “Application of Mid-Infrared Tuneable Diode Laser Absorption Spectroscopy to Plasma Diagnostics: A Review,” Plasma Sources Science and Technology, vol. 15, 2006, S148-S168.
Schaden et al., “Quantum Cascade Laser Modulation for Correction of Matrix-Induced Background Changes in Aqueous Samples,” Applied Physics B, vol. 86, 2007, pp. 347-351.
Sandt et al., “Identification of Spectral Modifications Occurring during Reprogramming of Somatic Cells,” PLoS ONE, vol. 7, Issue 4, e30743, Apr. 2012, 7 pages.
USPTO, “Non-Final Office Action,” issued in connection with U.S. Appl. No. 17/403,642, dated Nov. 29, 2021, 13 pages.
Intellectual Property India, “Examination Report,” issued in connection with Indian Patent Application No. 201917009874, dated Nov. 25, 2021, 6 pages.
Australian Office Action, Application No. 2017323502, dated Oct. 22, 2021, 6 pages.
Jokinen, Ville, et al. “Durable superhydrophobicity in embossed CYTOP fluoropolymer micro and nanostructures”, Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 434, 2013, pp. 207-212.
Forsberg, Pontus, Fredrik Nikolajeff, and Mikael Karlsson, “Cassie-Wenzel and Wenzel-Cassie transitions on immersed superhydrophobic surfaces under hydrostatic pressure”, Soft Matter, vol. 7, No. 1, 2011, pp. 104-109.
Lu, Hang, Martin A. Schmidt, and Klavs F. Jensen, “Photochemical reactions and on-line UV detection in microfabricated reactors”, Lab on a Chip, vol. 1, No. 1, 2001, pp. 22-28.
Japan Patent Office, “Office Action,” issued in connection with Japanese Patent Application No. 2019-513891, dated Jun. 24, 2021, 11 pages.
Brazilian Office Action, Application No. BR112019004727-1, dated Jul. 6, 2021, 4 pages.
Australian Office Action, Application No. 2017323502, dated Jun. 28, 2021, 6 pages.
China Office Action, Application No. 201780056064.5, dated Apr. 26, 2021, 8 pages.
China Office Action, Application No. 201780056064.5, dated Nov. 4, 2020 11 pages.
Europe Office Action, Application No. 17808998.3, dated Jul. 21, 2020.
Pedreira Carlos E et al: “Overview of clinical flow cytometry data analysis: recent advances and future challenges”, Trends in Biotechnology, Elsevier Publications, Cambridge, GB, vol. 31, No. 7, Jun. 5, 2013.
China Patent Office, “The Third Office Action,” issued in connection with China Patent Application No. 201480071952.0, dated Jul. 23, 2020, 23 pages.
Intellectual Property India, “Examination Report,” issued in connection with Indian Patent Application No. 3429/DELNP/2015, dated Mar. 26, 2018, 6 pages.
European Patent Office,“European Search Report,” issued in connection with patent application No. 20167363.9, dated Jul. 21, 2020, 9 pages.
Japan Patent Office, “Notice of Reasons for Refusal,” issued in connection with Japan Patent Application No. 2018-220397, dated Aug. 5, 2020, 3 pages.
European Patent Office, “Examination Report,” issued in connection with European Patent Application No. 16723498.8, dated Oct. 12, 2020, 6 pages.
European Patent Office, “European Search Report,” issued in connection with European Patent Application No. 14168200.5, dated Mar. 20, 2015, 12 pages.
European Patent Office, “European Search Report,” issued in connection with European Patent Application No. 17172322.4, dated Aug. 24, 2017, 8 pages.
European Patent Office, “European Search Report,” issued in connection with European Patent Application No. 15160613.4, dated Jul. 24, 2015, 14 pages.
European Patent Office, “Communication pursuant to Article 94(3) EPC,” issued in connection with European Patent Application No. 17172322.4, dated Aug. 14, 2018, 5 pages.
European Patent Office, “Communication pursuant to Article 94(3) EPC,” issued in connection with European Patent Application No. 11193936.9, dated Dec. 11, 2015, 3 pages.
European Patent Office, “Communication pursuant to Article 94(3) EPC,” issued in connection with European Patent Application No. 15160613.4, dated Jul. 11, 2016, 4 pages.
Hori et al., “Cell fusion by optical trapping with laser-involves contacting different cells with each other then imparting high voltage pulse to cells,” WPI/Thompson, Dec. 27, 1991, Abstract, 1 page.
Japan Patent Office, “Notification of Reasons for Refusal,” issued in connection with Japanese Patent Application No. 2016-185743, dated Jul. 3, 2018, 7 pages.
Japan Patent Office, “Final Notification of Reasons for Rejection,” issued in connection with Japanese Patent Application No. 2011-256171, dated Oct. 28, 2014, 5 pages.
Japan Patent Office, “Decision for Grant,” issued in connection with Japanese Patent Application No. 2015-091320, dated May 6, 2017, 7 pages.
Japan Patent Office, “Final Notification of Reasons for Rejection,” issued in connection with Japanese Patent Application No. 2015-091320, dated Mar. 22, 2016, 22 pages.
Japan Patent Office, “Notification of Reasons for Refusal,” issued in connection with Japanese Patent Application No. 2016-185743, dated Jul. 26, 2017, 2 pages.
Smith et al., “Inexpensive Optical Tweezers for Undergraduate Laboratories,” Am. J. Phys., vol. 67, No. 1, Jan. 1999, 10 pages.
Takayama et al., “Patterning Cells and Their Environments Using Multiple Laminar Fluid Flows in Capillary Networks,” Proceedings of National Academy of Sciences, vol. 96, 1999, 4 pages.
Ts'O, Basic Principles in Nucleic Acid Chemistry, National Library of Medicine, 1974, pp. 311-387.
International Preliminary Report on Patentability corresponding to International Patent Application No. PCT/US2013/050669, dated Jan. 28, 2016, 15 pages.
Supplementary European Search Report for Application No. 13889551, dated May 22, 2017, 12 pages.
State Intellectual Property Office of People's Republic of China, “Second Office Action,” issued in connection with Chinese Patent Application No. 201380079634.4, dated Jun. 4, 2018, 14 pages.
Japan Patent Office, “Notice of Reasons for Rejection,” issued in connection with Japanese Patent Application No. 2017-168904, dated Jul. 6, 2018, 3 pages.
State Intellectual Property Office of People's Republic of China, “Third Office Action,” issued in connection with Chinese Patent Application No. 201380079634.4, dated Nov. 1, 2018, 20 pages.
Japanese Office Action for Application No. 2016-527978 dated Mar. 28, 2017, 8 pages.
State Intellectual Property Office of People's Republic of China, “First Office Action,” issued in connection with Chinese Patent Application No. 201380079634.4, dated Jul. 28, 2017, 18 pages.
Indian Patent Application No. 3425/DELNP/2015 Pre-Grant Opposition, dated Dec. 4, 2020, 138 pages.
Indian Patent Application No. 3425/DELNP/2015 Pre-Grant Opposition, dated Jul. 21, 2020, 59 pages.
Indian Patent Application No. 3425/DELNP/2015 Pre-Grant Opposition, dated Jul. 21, 2020, 96 pages.
Indian Patent Application No. 3425/DELNP/2015 Pre-Grant Opposition, dated Jul. 2, 2020, 137 pages.
USPTO, “Non-Final Office Action,” issued in connection with U.S. Appl. No. 17/458,947, dated Dec. 15, 2021, 9 pages.
USPTO, “Notice of Allowance,” issued in connection with U.S. Appl. No. 16/864,514, dated Jan. 3, 2022, 24 pages.
USPTO, “Non-Final Office Action,” issued in connection with U.S. Appl. No. 16/852,303, dated Jan. 6, 2022, 27 pages.
Intellectual Property India, “Examination Report,” issued in connection with Indian Patent Application No. 202147003036, dated Jan. 4, 2022, 5 pages.
China Patent Office, “The Fifth Office Action,” issued in connection with China Patent Application No. 2014800719520, dated Oct. 20, 2021, 7 pages.
Intellectual Property India, “Examination Report,” issued in connection with Indian Patent Application No. 202017054203, dated Jan. 7, 2022, 5 pages.
Australian Office Action, Application No. 2021200818, dated Mar. 4, 2022, 3 pages.
Kang, et al. “Effect of an osmotic differential on the efficiency of gene transfer by electroporation offish spermatozoa.” Aquaculture 173.1-4 (1999): 297-307. (Year: 1999).
Rieth et al. “Electroporation of bovine spermatozoa to carry DNA containing highly repetitive sequences into oocytes and detection of homologous recombination events.” Molecular Reproduction and Development: Incorporating Gamete Research 57.4 (2000): 338-345.
Chamberland et al. “The effect of heparin on motility parameters and protein phosphorylation during bovine sperm capacitation. ”Theriogenology 55.3 (2001): 823-835. (Year: 2001).
Chan, et al. “Luminescent quantum dots for multiplexed biological detection and imaging.” Current opinion in biotechnology 13.1 (2002): 40-46. (Year: 2002).
USPTO, “Non-Final Office Action,” issued in connection with U.S. Appl. No. 16/561,146, dated Jan. 21, 2022, 14 pages.
USPTO, “Non-Final Office Action,” issued in connection with U.S. Appl. No. 17/496,469, dated Jan. 28, 2022, 13 pages.
USPTO, “Final Office Action,” issued in connection with U.S. Appl. No. 17/403,642, dated Mar. 4, 2022, 14 pages.
Related Publications (1)
Number Date Country
20190358634 A1 Nov 2019 US
Provisional Applications (1)
Number Date Country
62675512 May 2018 US